Combination of LABA + inhaled glucocorticoid safe in asthma

(HealthDay)—Compared to treatment with an inhaled glucocorticoid alone, combination therapy with a long-acting β2-agonist (LABA) and an inhaled glucocorticoid is not associated with a significantly hi

Updated on: April 16,2024

Combination of LABA + inhaled glucocorticoid safe in asthma

(HealthDay)—Compared to treatment with an inhaled glucocorticoid alone, combination therapy with a long-acting β2-agonist (LABA) and an inhaled glucocorticoid is not associated with a significantly hi

Updated on:April 16,2024

Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study

by Yolanda Poffenroth, Michael Brown,University of AlbertaCredit: Pixabay/CC0 Public DomainPermanent hearing loss triggered by a common chemotherapy drug in half of children being treated for ca

Updated on: May 07,2024

Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study

by Yolanda Poffenroth, Michael Brown,University of AlbertaCredit: Pixabay/CC0 Public DomainPermanent hearing loss triggered by a common chemotherapy drug in half of children being treated for ca

Updated on:May 07,2024

Filling data gaps: Gender equity in academic rheumatology

by European Alliance of Associations for Rheumatology, EULARTypical self-reported working hours in a week by role and gender, EULAR and EMEUNET members, 323 responses. The box and whisker chart shows

Updated on: June 01,2024

Filling data gaps: Gender equity in academic rheumatology

by European Alliance of Associations for Rheumatology, EULARTypical self-reported working hours in a week by role and gender, EULAR and EMEUNET members, 323 responses. The box and whisker chart shows

Updated on:June 01,2024

Discovery of how to limit asthma attack damage could stop disease

byKing's College LondonCredit: CC0 Public DomainScientists at King's College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-thre

Updated on: April 30,2024

Discovery of how to limit asthma attack damage could stop disease

byKing's College LondonCredit: CC0 Public DomainScientists at King's College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-thre

Updated on:April 30,2024

High body temperature increases resistance to pathogenic viral infections, new study finds

by University of Tokyo"Influenza Virus" by NIAID. Credit: Minami Nagai, Miyu Moriyama, Chiharu Ishii, Hirotake Mori, Hikaru Watanabe, Taku Nakahara, Takuji Yamada, Dai Ishikawa, Takamas

Updated on: May 06,2024

High body temperature increases resistance to pathogenic viral infections, new study finds

by University of Tokyo"Influenza Virus" by NIAID. Credit: Minami Nagai, Miyu Moriyama, Chiharu Ishii, Hirotake Mori, Hikaru Watanabe, Taku Nakahara, Takuji Yamada, Dai Ishikawa, Takamas

Updated on:May 06,2024

COVID vaccines also help protect HIV patients

by Ruhr-Universitaet-BochumAnti-RBD titers in vaccinated PLWH and HIV-negative controls. (A) Scheme showing the two groups of the study - control (n = 20) and people living with HIV (PLWH; n = 71

Updated on: April 09,2024

COVID vaccines also help protect HIV patients

by Ruhr-Universitaet-BochumAnti-RBD titers in vaccinated PLWH and HIV-negative controls. (A) Scheme showing the two groups of the study - control (n = 20) and people living with HIV (PLWH; n = 71

Updated on:April 09,2024

Study finds opioids double risk of venous thromboembolism in rheumatoid arthritis patients

by American College of RheumatologyRisk of outcomes (HR, 95% CI) with opioid initiation compared to NSAID initiation after adjustment for propensity score weights and imbalanced covariables (CVD

Updated on: May 13,2024

Study finds opioids double risk of venous thromboembolism in rheumatoid arthritis patients

by American College of RheumatologyRisk of outcomes (HR, 95% CI) with opioid initiation compared to NSAID initiation after adjustment for propensity score weights and imbalanced covariables (CVD

Updated on:May 13,2024

Psoriasis patients can get clearer skin with at-home treatment instead of at doctors' offices, study suggests

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: Estzer Miller on PixabayFor decades, people with psoriasis have been treated in clinics with narrowband ultra

Updated on: October 28,2024

Psoriasis patients can get clearer skin with at-home treatment instead of at doctors' offices, study suggests

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: Estzer Miller on PixabayFor decades, people with psoriasis have been treated in clinics with narrowband ultra

Updated on:October 28,2024

New method is better able to map immune response and paves way for new treatments

byKarolinska InstitutetSpatial transcriptomics–based method to map B cell and T cell receptors.Targeted capture of antigen receptor sequences from spatial transcriptomics gene expression librari

Updated on: January 26,2024

New method is better able to map immune response and paves way for new treatments

byKarolinska InstitutetSpatial transcriptomics–based method to map B cell and T cell receptors.Targeted capture of antigen receptor sequences from spatial transcriptomics gene expression librari

Updated on:January 26,2024

Joint cell finding gives clues for improved treatment of rheumatoid arthritis

by University of GlasgowThe key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long-term remission.The study—pub

Updated on: May 13,2024

Joint cell finding gives clues for improved treatment of rheumatoid arthritis

by University of GlasgowThe key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long-term remission.The study—pub

Updated on:May 13,2024

Immunity after COVID-19 illness may last at least 1 year

by Ernie MundellLong-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in

Updated on: April 10,2024

Immunity after COVID-19 illness may last at least 1 year

by Ernie MundellLong-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in

Updated on:April 10,2024

New strategy for COVID-19 prophylaxis

by University of BonnPhD student Samira Marx and Prof. Dr. Gunther Hartmann - of the Cluster of Excellence ImmunoSensation2 at the University of Bonn in the lab. Credit: David FußhöllerSARS-CoV-2

Updated on: April 13,2024

New strategy for COVID-19 prophylaxis

by University of BonnPhD student Samira Marx and Prof. Dr. Gunther Hartmann - of the Cluster of Excellence ImmunoSensation2 at the University of Bonn in the lab. Credit: David FußhöllerSARS-CoV-2

Updated on:April 13,2024